DrugPatentWatch Database Preview
Details for Patent: 6,479,496
Which drugs does patent 6,479,496 protect, and when does it expire?
Patent 6,479,496 protects RANEXA and is included in one NDA.
This patent has ninety-eight patent family members in twenty-nine countries.
Summary for Patent: 6,479,496
| Title: | Methods for treating angina with ranolazine |
| Abstract: | A sustained release ranolazine formulation contains an intimate mixture of ranolazine and a partially neutralized pH-dependent binder to form a film that is mostly insoluble in aqueous media below pH 4.5 and soluble in aqueous media above pH 4.5. The formulation is suitable for twice daily administration of ranolazine and is useful for controlling the rate of dissolution of ranolazine, and to maintain human plasma ranolazine levels at between 850 and 4000 ng base/mL. |
| Inventor(s): | Wolff; Andrew A. (San Francisco, CA) |
| Assignee: | CV Therapeutics, Inc. (Palo Alto, CA) |
| Application Number: | 09/520,932 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,479,496 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 6,479,496
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gilead | RANEXA | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 021526-001 | Feb 12, 2007 | AB | RX | Yes | Yes | Start Trial | Start Trial | TREATING CHRONIC ANGINA BY ADMINISTERING AN EXTENDED RELEASE FORM OF RANOLAZINE | Start Trial | |||
| Gilead | RANEXA | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 021526-002 | Jan 27, 2006 | AB | RX | Yes | No | Start Trial | Start Trial | TREATING CHRONIC ANGINA BY ADMINISTERING AN EXTENDED RELEASE FORM OF RANOLAZINE | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,479,496
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 022085 | Start Trial | |||
| Argentina | 052921 | Start Trial | |||
| Argentina | 053440 | Start Trial | |||
| Austria | 217794 | Start Trial | |||
| Austria | 285774 | Start Trial | |||
| Australia | 2001240092 | Start Trial | |||
| Australia | 2008207703 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
